ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Condition : Alphabetically : A : Alzheimer Disease


Include trials that are no longer recruiting patients.

50 studies were found.
1.RecruitingAlzheimer's Disease Genetics Study
Conditions: Alzheimer Disease; Late Onset Alzheimer Disease
2.RecruitingEvaluation of Age- and Alzheimer's Disease-Related Memory Disorder
Conditions: Alzheimer Disease; Dementia; Memory Disorder; Healthy
3.RecruitingBrain Study of Patients with Frontal Lobe Dementia and Parkinsonian Disorders
Conditions: Alzheimer's Disease; Dementia; Down's Syndrome
4.RecruitingAlzheimer's Disease: Therapeutic Potential of Estrogen
Condition: Alzheimer Disease
5.RecruitingPredictors of Cognitive Decline in Normal Aging
Conditions: Alzheimer Disease; Dementia
6.RecruitingRisk Evaluation and Education for Alzheimer’s Disease (REVEAL) II
Condition: Alzheimer Disease
7.RecruitingEvaluation of Alzhemed™ in Patients with Mild to Moderate Alzheimer’s Disease
Condition: Alzheimer Disease
8.RecruitingEffect of Lithium and Divalproex in Alzheimer's Disease
Condition: Alzheimer Disease
9.RecruitingHuperzine A in Alzheimer's Disease
Condition: Alzheimer Disease
10.RecruitingAntigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study
Condition: Alzheimer Disease
11.RecruitingValproate in Dementia (VALID)
Condition: Alzheimer Disease
12.RecruitingCognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease
Condition: Alzheimer Disease
13.RecruitingAlzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
Condition: Alzheimer Disease
14.RecruitingBathing persons with Alzheimer's disease aT Home (The BATH Study)
Condition: Alzheimer Disease
15.RecruitingAlzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II
Condition: Alzheimer Disease
16.RecruitingVitamin E in Aging Persons With Down Syndrome
Conditions: Down Syndrome; Alzheimer Disease
17.RecruitingPrevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
Condition: Alzheimer Disease
18.RecruitingEffects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease
Condition: Alzheimer Disease
19.RecruitingPET Changes in Alzheimer's Disease (AD)
Condition: Alzheimer Disease
20.RecruitingCholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study
Condition: Alzheimer Disease
21.RecruitingEffects of an Anti-Inflammatory Drug in Alzheimer's Disease
Condition: Alzheimer's Disease
22.RecruitingThe Effect of Short-Term Statins and NSAIDs on Levels of Beta-Amyloid, a Protein Associated with Alzheimer's Disease
Condition: Alzheimer Disease
23.RecruitingSGS742 in Patients with Mild to Moderate Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
24.RecruitingDiagnosis and Natural History Study of Patients with Neurological Conditions
Conditions: Alzheimer's Disease; Dementia; Movement Disorder; Multiple System Atrophy; Parkinson's Disease
25.RecruitingThe Evaluation and Follow-up of Individuals with Memory Disorder
Conditions: Alzheimer's Disease; Dementia; Healthy; Memory Disorder
26.RecruitingGene-Environment Interactions in Alzheimer's Disease
Condition: Alzheimer's Disease
27.RecruitingBiomarkers and Early Alzheimer's Disease
Condition: Alzheimer's Disease
28.RecruitingTreatment of Alzheimer's Disease with CX516 (Ampalex)
Conditions: Alzheimer's Disease; Dementia
29.RecruitingEfficacy and Safety of LY451395 in Patients with Probable Alzheimer's Disease
Condition: Alzheimer's Disease
30.RecruitingBrain Imaging in Elderly People and Individuals with Alzheimer's Disease
Conditions: Alzheimer's Disease; Healthy
31.RecruitingCERE-110 in Subjects with Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
32.RecruitingDepression in Alzheimer's Disease (DIADS-2)
Conditions: Alzheimer's Disease; Depression
33.RecruitingSafety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer’s Disease
Condition: Alzheimer's Disease
34.RecruitingHigh Intensity Light Therapy in Alzheimer's Disease
Conditions: Alzheimer's Disease; Dementia
35.RecruitingNS 2330 in Patients with Mild to Moderate Dementia of the Alzheimer’s Type
Condition: Alzheimer Disease
36.RecruitingInsulin, Neurogenetics and Memory in Alzheimer's Disease
Condition: Alzheimer Disease
37.RecruitingDelaying Alzheimer Disease Symptoms with Anti-Inflammatory Drugs
Conditions: Alzheimer Disease; Dementia
38.RecruitingElectrophysiologic Measures of Treatment Response in Alzheimer Disease
Condition: Alzheimer Disease
39.RecruitingTreating Behavioral Disturbances in Individuals with Dementia
Conditions: Dementia; Alzheimer Disease
40.RecruitingAlzheimer's Disease and Aging: Therapeutic potential of estrogen
Condition: Alzheimer's Disease
41.RecruitingSafety testing of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Laughter & Crying)
Conditions: Amyotrophic Lateral Sclerosis; Multiple Sclerosis; Alzheimer's Disease; Stroke; Traumatic Brain Injury
42.RecruitingA Randomized Study to Evaluate FK962 in Subjects with Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
43.RecruitingVITAL - VITamins to slow ALzheimer's disease (Homocysteine Study)
Condition: Alzheimer's Disease
44.RecruitingEffects of ONO-2506PO in Patients with Alzheimer's Disease
Condition: Alzheimer's Disease
45.RecruitingIntramuscular Aripiprazole in Acutely Agitated Patients Diagnosed with Dementia
Conditions: Dementia; Alzheimer's Disease
46.RecruitingThe Safety and Efficacy of Neramexane in Patients with Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
47.RecruitingPrevention of cognitive decline in Alzheimer's disease by ingested interferon alpha
Conditions: Memory Disorders; Alzheimer's Disease
48.RecruitingSpecific Interventions for Agitation in Alzheimer's Disease
Conditions: Alzheimer's Disease; Dementia
49.RecruitingFish Oil and Alpha Lipoic Acid in Treating Alzheimer’s Disease
Conditions: Alzheimer's Disease; Oxidative Stress; Dementia; Hyperlipidemia; Inflammation
50.RecruitingTreatment Study of Frontotemporal Dementia
Condition: Frontotemporal Lobar Degeneration

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act